Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why ANI Pharmaceuticals Inc. Shares Shot Higher

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of ANI Pharmaceuticals (NASDAQ: ANIP  ) , a specialist in the development and marketing of branded and generic pharmaceutical products, jumped as much as 15% after the company reported fourth-quarter earnings results.

So what: Given that ANI Pharmaceuticals is a smaller company (with a market cap just above $200 million) there were no Wall Street estimates to match up to, allowing investors to push its share price higher or lower based solely on the raw results. For the quarter, revenue rose 98% to $10.5 million, from $5.3 million in the prior year. Net income tallied $3.4 million, or $0.35 per share, and reversed a year-ago loss of nearly $1.2 million. ANI noted that prescription sale revenue spiked 170% during the quarter to $8.8 million, primarily due to better sales and a higher price for its Esterified Estrogens with Methyltestosterone Tablet, or EEMT. During the quarter, ANI also announced the acquisition of 31 generic products from Teva Pharmaceutical (NYSE: TEVA  ) for $12.5 million, bringing its current and developing pipeline to 38 products.

Now what: Simply put, this is what happens when a company grows its top line organically and turns losses into profits. It's especially beautiful because we get to witness the reaction of shareholders who have not been clouded by Wall Street's "guesstimates." If ANI is already profitable from its EEMT product, chances are good that the addition of Teva's generic products is only going to further boost that profitability in 2014. ANI has already had quite the run, so I'm a bit skeptical about insinuating that it could head even higher, but that isn't out of the question.

ANI Pharmaceuticals may be roaring higher today, but it'll likely be hard-pressed to keep up with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2843183, ~/Articles/ArticleHandler.aspx, 8/28/2015 1:14:21 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and in investment planning topics. You'll usually find him writing about Obamacare, marijuana, developing drugs, diagnostics, and medical devices, Social Security, taxes, or any number of other macroeconomic issues.

Today's Market

updated 3 hours ago Sponsored by:
DOW 16,654.77 369.26 2.27%
S&P 500 1,987.66 47.15 2.43%
NASD 4,812.71 115.17 2.45%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/27/2015 4:00 PM
ANIP $50.09 Up +0.03 +0.06%
ANI Pharmaceutical… CAPS Rating: ***
TEVA $65.20 Up +0.38 +0.59%
Teva Pharmaceutica… CAPS Rating: *****